Georgina Silva-Da

Ferreira, 4050313, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

The impact of cannabigerol exposure on human endometrial stromal cells decidualization.

The impact of cannabigerol exposure on human endometrial stromal cells decidualization.

Journal: Toxicology

Published: March 12, 2026

Cutting-edge design approaches for steroidal aromatase inhibitors: new horizons for hormone-dependent cancer.

Cutting-edge design approaches for steroidal aromatase inhibitors: new horizons for hormone-dependent cancer.

Journal: Expert opinion on drug discovery

Published: December 19, 2025

Effects of cannabidiol, cannabichromene, cannabidivarin, cannabigerol and cannabinol in endometrial cells: Implications for endocrine and senescence modulation.

Effects of cannabidiol, cannabichromene, cannabidivarin, cannabigerol and cannabinol in endometrial cells: Implications for endocrine and senescence modulation.

Journal: Reproductive toxicology (Elmsford, N.Y.)

Published: April 21, 2025

Automated renewable label-free optical sensor for quantification of therapeutic monoclonal antibodies.

Automated renewable label-free optical sensor for quantification of therapeutic monoclonal antibodies.

Journal: Talanta

Published: March 27, 2025

Cannabinol improves exemestane efficacy in estrogen receptor-positive breast cancer models: a comparative study with cannabidiol.

Cannabinol improves exemestane efficacy in estrogen receptor-positive breast cancer models: a comparative study with cannabidiol.

Journal: European journal of pharmacology

Published: February 24, 2025

Impact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer.

Impact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: February 03, 2025

Specialized pro-resolving mediators: key regulators in placental function and pregnancy complications.

Specialized pro-resolving mediators: key regulators in placental function and pregnancy complications.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: January 08, 2025

New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment.

New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment.

Journal: Cancers

Published: November 27, 2024

Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies.

Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 17, 2024

Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells.

Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells.

Journal: Archives of toxicology

Published: February 23, 2024

Alterations in the pro-resolving lipid mediator machinery within first trimester maternal tissue: Implications in decidualization and miscarriage risk.

Alterations in the pro-resolving lipid mediator machinery within first trimester maternal tissue: Implications in decidualization and miscarriage risk.

Journal: Prostaglandins, leukotrienes, and essential fatty acids

Published: January 29, 2024

Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies.

Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies.

Journal: Biochemical pharmacology

Published: December 28, 2023

Showing 1-12 of 94

Last Updated: 09/26/2026